MENU
ROIV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Roivant Sciences (ROIV) Ownership - Who owns Roivant Sciences?
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients... Show more
Profile
Industry
N/A
Address
50 Broadway
Phone
+44 2074003347
Employees
904
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.84B
P/E Ratio
1.97
Total Cash
4.89B
Projected Growth
N/A
Total Debt
100.17M
Revenue
29.05M
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash/Share
7.16
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
ROIV
Capitalization
7.84B
P/E Ratio
1.97
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash
4.89B
Total Cash/Share
7.16
Total Debt
100M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
29.1M
ROE
N/A
Book Value
4.69B
P/B Ratio
1.67
Cash Flow
N/A
Earnings
-0.24
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
33.47
Current Revenue Per Employee
10093.33
Dividends Per Share - Security
N/A
EBITDA
-1.1B
Float
N/A
Float - Current
N/A
Gross Income Margin
97.29
Revenue To Assets
-2.72
Shares Held By Institutions
9.76B
Shares Outstanding - Current
683M
Total Liabilities
250M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-2.874
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ROIV showed earnings on May 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
50 Broadway
Phone
+44 2074003347
Employees
904
Web
N/A